Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (73)
Oncogene (5)
Nature Photonics (1)
Nature Reviews Cancer (1)
Nature Reviews Drug Discovery (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (72)
Reviews (8)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biomarkers
Biophysics
Cancer
Cell biology
Diseases
Drug discovery
Evolution
Genetics
Health care
Medical research
Microbiology
Molecular biology
Oncology
Optics and photonics
Pathogenesis
Physics
Physiology
Signs and symptoms

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 81 results

Advanced filters: Author: M Koukourakis Clear advanced filters

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

M I Koukourakis
N Bahlitzanakis
K Beroukas
ResearchOpen Access09 Jul 1999
British Journal of Cancer

Volume: 80, P: 1792-1796
Concurrent administration of Docetaxel and Stealth^® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection

M I Koukourakis
K Romanidis
N Bahlitzanakis
ResearchOpen Access06 Aug 2002
British Journal of Cancer

Volume: 87, P: 385-392
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

A Giatromanolaki
M I Koukourakis
A L Harris
ResearchOpen Access11 Sept 2001
British Journal of Cancer

Volume: 85, P: 881-890
High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

M I Koukourakis
S Koukouraki
N Karkavitsas
ResearchOpen Access24 Oct 2000
British Journal of Cancer

Volume: 83, P: 1281-1286
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

A Giatromanolaki
M I Koukourakis
A L Harris
ResearchOpen Access21 Aug 2012
British Journal of Cancer

Volume: 107, P: 1044-1050
Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?

M I Koukourakis
A Giatromanolaki
E Sivridis
ResearchOpen Access04 Mar 2003
British Journal of Cancer

Volume: 88, P: 711-717
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

K J O'Byrne
M I Koukourakis
A L Harris
ResearchOpen Access21 Mar 2000
British Journal of Cancer

Volume: 82, P: 1427-1432
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

M Scartozzi
R Giampieri
S Cascinu
ResearchOpen Access07 Feb 2012
British Journal of Cancer

Volume: 106, P: 799-804
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

M I Koukourakis
A Giatromanolaki
A L Harris
ResearchOpen Access26 Aug 2003
British Journal of Cancer

Volume: 89, P: 877-885
Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy

M I Koukourakis
A Giatromanolaki
E Sivridis
ResearchOpen Access08 Apr 2014
British Journal of Cancer

Volume: 110, P: 2217-2223
Aberrant methylation of SPARC in human lung cancers

M Suzuki
C Hao
A F Gazdar
ResearchOpen Access01 Mar 2005
British Journal of Cancer

Volume: 92, P: 942-948
Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?

R Cooper
S Sarioğlu
C West
ResearchOpen Access26 Aug 2003
British Journal of Cancer

Volume: 89, P: 870-876
Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

MI Koukourakis
A Giatromanolaki
AL Harris
Research01 Feb 1997
British Journal of Cancer

Volume: 75, P: 477-481
PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer

S M Wigfield
S C Winter
A L Harris
ResearchOpen Access10 Jun 2008
British Journal of Cancer

Volume: 98, P: 1975-1984
Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

M I Koukourakis
A Giatromanolaki
A L Harris
ResearchOpen Access14 Sept 2010
British Journal of Cancer

Volume: 103, P: 1209-1214
Reply: ^99mTc-labelled Stealth liposomal doxorubicin (Caelyx^®) in glioblastomas and metastatic brain tumours

M I Koukourakis
CorrespondenceOpen Access12 Feb 2002
British Journal of Cancer

Volume: 86, P: 660-661
Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis

E Sivridis
A Giatromanolaki
M I Koukourakis
ResearchOpen Access07 May 2002
British Journal of Cancer

Volume: 86, P: 1465-1471
Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection

S Zoula
P F J W Rijken
C Rémy
ResearchOpen Access29 Apr 2003
British Journal of Cancer

Volume: 88, P: 1439-1444
Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

R Hitt
A Jimeno
H Cortés-Funes
ResearchOpen Access14 Dec 2004
British Journal of Cancer

Volume: 91, P: 2005-2011
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia

M Maftouh
A Avan
E Giovannetti
ResearchOpen Access31 Oct 2013
British Journal of Cancer

Volume: 110, P: 172-182
CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma

T Fukusumi
H Ishii
H Inohara
ResearchOpen Access29 May 2014
British Journal of Cancer

Volume: 111, P: 506-514
Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy

T Kawaguchi
S Yamamoto
K Furuse
ResearchOpen Access17 Dec 1999
British Journal of Cancer

Volume: 82, P: 418-423
The hypoxia-inducible factor-1α is a negative factor for tumor therapy

Annika Unruh
Anke Ressel
Roland H Wenger
Research22 May 2003
Oncogene

Volume: 22, P: 3213-3220
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

A-P Meert
M Paesmans
J-P Sculier
ReviewsOpen Access23 Sept 2002
British Journal of Cancer

Volume: 87, P: 694-701
Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

M I Koukourakis
A Giatromanolaki
D Generali
ResearchOpen Access10 Apr 2014
British Journal of Cancer

Volume: 110, P: 2209-2216
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer

R J Shaw
M M Omar
J M Risk
ResearchOpen Access30 Jun 2009
British Journal of Cancer

Volume: 101, P: 139-144
Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage

T Kurokawa
M Miyamoto
H Katoh
ResearchOpen Access09 Sept 2003
British Journal of Cancer

Volume: 89, P: 1042-1047
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

B Martin
M Paesmans
J-P Sculier
ResearchOpen Access01 Jul 2003
British Journal of Cancer

Volume: 89, P: 55-64
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer

KJ O'Byrne
MI Koukourakis
DC Talbot
Research01 Jun 1998
British Journal of Cancer

Volume: 77, P: 1950-1956
Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo

H Yasui
A Ogura
O Inanami
ResearchOpen Access14 Oct 2008
British Journal of Cancer

Volume: 99, P: 1442-1452
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

M Schuyer
M E L van der Burg
E M J J Berns
ResearchOpen Access30 Oct 2001
British Journal of Cancer

Volume: 85, P: 1359-1367
Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization

L Boldrini
A Calcinai
G Fontanini
ResearchOpen Access25 Jul 2000
British Journal of Cancer

Volume: 83, P: 480-486
Consensus statement on Brillouin light scattering microscopy of biological materials

Brillouin scattering microscopy is prone to artefacts and inconsistencies. This Consensus statement provides recommendations for measuring and reporting relevant parameters with the aim of standardizing protocols and improving the comparability of studies.

Pierre Bouvet
Carlo Bevilacqua
Kareem Elsayad
Reviews03 Jul 2025
Nature Photonics

Volume: 19, P: 681-691
Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance

L Kaklamanis
MI Koukourakis
AL Harris
Research01 Nov 1996
British Journal of Cancer

Volume: 74, P: 1627-1631
ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix

Cs-F Hooi
C Blancher
I G Campbell
Research13 Feb 2006
Oncogene

Volume: 25, P: 3924-3933
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression

N Said
H F Frierson Jr
D Theodorescu
Research13 Jul 2009
Oncogene

Volume: 28, P: 3487-3498
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial

M Verstraete
A Debucquoy
K Haustermans
ResearchOpen Access17 Mar 2015
British Journal of Cancer

Volume: 112, P: 1314-1325
Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer

E Volkova
J A Willis
M J Currie
ResearchOpen Access16 Nov 2010
British Journal of Cancer

Volume: 104, P: 51-59
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues

There seem to be several overlapping processes that induce resistance to antibiotics for bacteria and chemotherapy for tumour cells. This Perspective discusses how our understanding of bacterial resistance to antibiotics might inform our understanding of the resistance of tumours to therapy.

Guillaume Lambert
Luis Estévez-Salmeron
Robert H. Austin
Reviews21 Apr 2011
Nature Reviews Cancer

Volume: 11, P: 375-382
Clinical experiences with systemically administered siRNA-based therapeutics in cancer

Several Phase I trials evaluating systemically administered siRNA-based therapeutics for cancer have recently been completed. Here, Zuckerman and Davis critically assess these studies and discuss key lessons learnt and implications for the future development of siRNA-based therapeutics and clinical trial design.

Jonathan E. Zuckerman
Mark E. Davis
Reviews16 Nov 2015
Nature Reviews Drug Discovery

Volume: 14, P: 843-856
Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

H Katori
M Tsukuda
K Yamamoto
ResearchOpen Access20 Jan 2004
British Journal of Cancer

Volume: 90, P: 348-352
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

J P Braybrooke
D J Propper
A L Harris
ResearchOpen Access20 Jun 2000
British Journal of Cancer

Volume: 83, P: 219-224
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness

E Blot
W Chen
C Soria
ResearchOpen Access15 Apr 2003
British Journal of Cancer

Volume: 88, P: 1207-1212
Expression of the thymidine phosphorylase gene in epithelial ovarian cancer

K Hata
T Kamikawa
M Fukumoto
ResearchOpen Access12 Mar 1999
British Journal of Cancer

Volume: 79, P: 1848-1854
Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer

M Toi
H Bando
S Ohno
ResearchOpen Access04 May 2004
British Journal of Cancer

Volume: 90, P: 2338-2343
Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer

MI Saunders
A Rojas
N Verma
Research01 Nov 1998
British Journal of Cancer

Volume: 78, P: 1323-1328
Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-β and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation

G Vlahovic
Z N Rabbani
Z Vujaskovic
ResearchOpen Access26 Sept 2006
British Journal of Cancer

Volume: 95, P: 1013-1019
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers

A Al-Attar
L Gossage
S Madhusudan
ResearchOpen Access19 Jan 2010
British Journal of Cancer

Volume: 102, P: 704-709
Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

P Michel
A Adenis
B Paillot
ResearchOpen Access12 Sept 2006
British Journal of Cancer

Volume: 95, P: 705-709
Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma

H Shimada
T Hoshino
T Ochiai
ResearchOpen Access12 Feb 2002
British Journal of Cancer

Volume: 86, P: 552-557

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2026 Springer Nature Limited